TG Therapeutics Inc.

39.38
-0.44 (-1.10%)
At close: Apr 03, 2025, 12:53 PM

TG Therapeutics Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2021Mar 31, 2021
License Revenue Revenue 38K 38K 66.94M 25.07M 1.51M 755K
License Revenue Revenue Growth 0.00% -99.94% +167.02% +1563.44% +99.60% n/a
Other Revenue Revenue 315K 415K n/a n/a n/a n/a
Other Revenue Revenue Growth -24.10% n/a n/a n/a n/a n/a
Product Revenue 83.3M 50.49M n/a n/a n/a n/a
Product Revenue Growth +64.98% n/a n/a n/a n/a n/a
Royalty Revenue 229K 33K n/a n/a n/a n/a
Royalty Revenue Growth +593.94% n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023
International Revenue 3.22M
International Revenue Growth n/a
Worldwide Revenue 92M
Worldwide Revenue Growth n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 41.97M 38.72M 34.5M 31.06M 26.5M 36.38M 29.65M 22.5M 17.5M 14.97M 22.5M 37.4M 34.9M 41.03M 34.27M 49.67M 39.91M 15.99M 16.24M 8.54M 4.4M 4.07M 3.83M 3.12M 1.61M 6.57M 9.46M 5.34M 6.29M 3.02M 7.33M 2.65M 4.09M 3.09M 2.8M 3.95M 2.33M 7.25M 6.36M
Selling, General, and Administrative Revenue Growth +8.39% +12.23% +11.07% +17.21% -27.16% +22.69% +31.76% +28.57% +16.95% -33.50% -39.83% +7.16% -14.95% +19.72% -31.00% +24.44% +149.67% -1.56% +90.07% +94.36% +8.06% +6.19% +22.83% +93.49% -75.47% -30.51% +77.19% -15.14% +107.96% -58.74% +176.41% -35.10% +32.00% +10.54% -29.16% +69.95% -67.91% +13.93% n/a
Research and Development Revenue 20.14M 17.56M 32.72M 17.45M 11.84M 22.46M 14.29M 29.64M 17.55M 24.55M 46.15M 57.66M 51.97M 37.85M 55.58M 37.15M 45.85M 34.9M 34.04M 29.45M 56.5M 31.51M 30.9M 51.07M 32.75M 37.81M 32.16M 25.74M 25.33M 25.44M 20.38M 21.41M 20.88M 12.97M 11.23M 13.73M 11.54M 9.9M 8.28M
Research and Development Revenue Growth +14.71% -46.35% +87.53% +47.40% -47.29% +57.20% -51.79% +68.84% -28.49% -46.81% -19.97% +10.96% +37.28% -31.89% +49.62% -18.97% +31.38% +2.51% +15.58% -47.87% +79.29% +2.00% -39.50% +55.92% -13.38% +17.58% +24.96% +1.58% -0.41% +24.85% -4.85% +2.57% +61.01% +15.46% -18.18% +18.96% +16.52% +19.60% n/a